Funder
State Key Laboratory of Natural Medicines
Basic and Applied Basic Research Foundation of Guangdong Province
National Natural Science Foundation of China
Science, Technology and Innovation Commission of Shenzhen Municipality
Guangdong Medical Research Foundation
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference494 articles.
1. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study;Miyashita;Emerg Microb Infect,2023
2. Pathophysiology of COVID-19: critical role of hemostasis;de Andrade;Front Cell Infect Microbiol,2022
3. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials;Zeng;Lancet Infect Dis,2022
4. Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology;Wang;China J Chin Mater Med,2020
5. Efficacy and safety of nirmatrelvir/ritonavir, molnupiravir, and remdesivir in a real-world cohort of outpatients with COVID-19 at high risk of progression: the PISA outpatient clinic experience;Tiseo;Infect Dis Ther,2023
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献